⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001302618

SCHMIEG MARTIN E

Reports to the SEC for 3 companies · NEW YORK, NY

Transactions

6

Companies

3

Filings

4

CIK

0001302618

Forms 4 and 5

Insider transactions

6 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2012-06-25	LSTALISATA THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Vice President - Corporate Dev	AAward	+300K sh	—	—	300,000
2005-06-16	Fibrocell Science, Inc.P Purchase	CFO & Sr. Vice President	PPurchase	+5,000 sh	$3.83	+$19.2K	7,300
2005-02-03	SIRNA THERAPEUTICS INCIncentive Stock OptionA Award	Sr. Vice President & CFO	AAward	+2,500 sh	—	—	2,500
2005-02-03	SIRNA THERAPEUTICS INCNon Qualified Stock OptionA Award	Sr. Vice President & CFO	AAward	+57.5K sh	—	—	57,500
2004-09-20	SIRNA THERAPEUTICS INCINCENTIVE STOCK OPTIONA Award	Sr. Vice President & CFO	AAward	+132K sh	—	—	132,012
2004-09-20	SIRNA THERAPEUTICS INCNON-QUAL STOCK OPTIONA Award	Sr. Vice President & CFO	AAward	+118K sh	—	—	117,988

Recent filings

4

Accepted (ET)
Jun 274
SCHMIEG MARTIN E0001144204-12-036785
SEC(opens sec.gov)
Jun 164
ISOLAGEN INC0001104659-05-028549
SEC(opens sec.gov)
Feb 74
SCHMIEG MARTIN E0001181431-05-007625
SEC(opens sec.gov)
Sep 214
SCHMIEG MARTIN E0001181431-04-044534
SEC(opens sec.gov)

Companies

3

Address

C/O NEOSTEM, INC. 420 LEXINGTON AVENUE, SUITE 450

NEW YORK, NY, 10170